Literature DB >> 18632217

FDG-PET-based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning--an intraindividual comparison.

Aleksandar Grgic1, Ursula Nestle, Andrea Schaefer-Schuler, Stephanie Kremp, Carl-Martin Kirsch, Dirk Hellwig.   

Abstract

PURPOSE: Fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET) and PET/computed tomography (CT) are increasingly used for radiotherapy (RT) planning in patients with non-small-cell lung carcinoma. The planning process often is based on separately acquired FDG-PET/CT and planning CT scans. We compared intraindividual differences between PET acquired in diagnostic (D-PET) and RT treatment position (RT-PET) coregistered with planning CTs acquired using different breathing protocols. METHODS AND MATERIALS: Sixteen patients with non-small-cell lung carcinoma underwent two PET acquisitions (D-PET and RT-PET) and three planning CT acquisitions (expiration [EXP], inspiration [INS], and mid-breath hold [MID]) on the same day. All scans were rigidly coregistered, resulting in six fused data sets: D-INS, D-EXP, D-MID, RT-INS, RT-EXP, and RT-MID. Fusion accuracy was assessed by three readers at eight anatomic landmarks, lung apices, aortic arch, heart, spine, sternum, carina, diaphragm, and tumor, by using an alignment score ranging from 1 (no alignment) to 5 (exact alignment).
RESULTS: The RT-PET showed better alignment with any CT than D-PET (p < 0.001). With regard to breathing, RT-MID showed the best mean alignment score (3.7 +/- 1.0), followed by RT-EXP (3.5 +/- 0.9) and RT-INS (3.0 +/- 0.8), with all differences significant (p < 0.001). Comparing alignment scores with regard to anatomic landmarks, the largest deviations were found at the diaphragm, heart, and apices. Overall, there was fair agreement (kappa = 0.48; p < 0.001) among the three readers.
CONCLUSIONS: Significantly better fusion of PET and planning CT can be reached with PET acquired in the RT position. The best intraindividual fusion results are obtained with the planning CT performed during mid-breath hold. Our data justify the acquisition of a separate planning PET in RT treatment position if only a diagnostic PET scan is available.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632217     DOI: 10.1016/j.ijrobp.2008.03.063

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Recommendations for the use of PET and PET-CT for radiotherapy planning in research projects.

Authors:  E J Somer; L C Pike; P K Marsden
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

Review 2.  PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques.

Authors:  Habib Zaidi; Issam El Naqa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-25       Impact factor: 9.236

3.  Hybrid versus fusion imaging: are we moving forward judiciously?

Authors:  Luca Giovanella; Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05       Impact factor: 9.236

Review 4.  The use of FDG-PET to target tumors by radiotherapy.

Authors:  Guido Lammering; Dirk De Ruysscher; Angela van Baardwijk; Brigitta G Baumert; Jacques Borger; Ludy Lutgens; Piet van den Ende; Michel Ollers; Philippe Lambin
Journal:  Strahlenther Onkol       Date:  2010-08-30       Impact factor: 3.621

5.  Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification.

Authors:  Aleksandar Grgic; Yildirim Yüksel; Andreas Gröschel; Hans-Joachim Schäfers; Gerhard W Sybrecht; Carl-Martin Kirsch; Dirk Hellwig
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-06       Impact factor: 9.236

6.  Conventional 3D staging PET/CT in CT simulation for lung cancer: impact of rigid and deformable target volume alignments for radiotherapy treatment planning.

Authors:  G G Hanna; J R Van Sörnsen De Koste; K J Carson; J M O'Sullivan; A R Hounsell; S Senan
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

7.  Metabolic Tumor Volume on PET Reduced More than Gross Tumor Volume on CT during Radiotherapy in Patients with Non-Small Cell Lung Cancer Treated with 3DCRT or SBRT.

Authors:  Pawinee Mahasittiwat; Shuanghu Yuan; Congying Xie; Timothy Ritter; Yue Cao; Randall K Ten Haken; Feng-Ming Spring Kong
Journal:  J Radiat Oncol       Date:  2013-06

8.  Impact of rigid and nonrigid registration on the determination of 18F-FDG PET-based tumour volume and standardized uptake value in patients with lung cancer.

Authors:  Aleksandar Grgic; Elena Ballek; Jochen Fleckenstein; Norbert Moca; Stephanie Kremp; Andrea Schaefer; Jan-Martin Kuhnigk; Christian Rübe; Carl-Martin Kirsch; Dirk Hellwig
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-22       Impact factor: 9.236

9.  ICORG 06-35: a prospective evaluation of PET-CT scan in patients with non-operable or non-resectable non-small cell lung cancer treated by radical 3-dimensional conformal radiation therapy: a phase II study.

Authors:  Karla A Lee; Guhan Rangaswamy; Naomi A Lavan; Mary Dunne; Conor D Collins; Cormac Small; Pierre Thirion
Journal:  Ir J Med Sci       Date:  2019-05-06       Impact factor: 1.568

10.  A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data.

Authors:  Andrea Schaefer; Stephanie Kremp; Dirk Hellwig; Christian Rübe; Carl-Martin Kirsch; Ursula Nestle
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-26       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.